4,5-dimethoxy-2-nitrobenzaldehyde has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, JH; Kang, CD; Kim, DW; Kim, DY; Kim, HB; Kim, MJ; Kim, SH; Lee, JW | 1 |
1 other study(ies) available for 4,5-dimethoxy-2-nitrobenzaldehyde and Prostatic Neoplasms
| Article | Year |
|---|---|
High susceptibility of metastatic cells derived from human prostate and colon cancer cells to TRAIL and sensitization of TRAIL-insensitive primary cells to TRAIL by 4,5-dimethoxy-2-nitrobenzaldehyde.
Topics: Apoptosis; Benzaldehydes; Blotting, Western; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; DNA-Activated Protein Kinase; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, TNF-Related Apoptosis-Inducing Ligand; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2011 |